Skip to content
CancerIndex

Publication

Clinical and molecular characteristics of MEF2D fusion-positive B-cell precursor acute lymphoblastic leukemia in childhood, including a novel translocation resulting in MEF2D-HNRNPH1 gene fusion.

Authors not recorded

Haematologica2019PMID 30171027PMC6312004stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 2

Curated evidence

Evidence citing this paper (1)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
30171027
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
MEF2D Fusion1
(diagnostic)B-lymphoblastic Leukemia With MEF2D RearrangementUNRESOLVEDDiagnosticBSupports Positive4accepted
EID12178

This study gathered diagnostic and prognostic data from pediatric B-cell acute lymphoblastic leukemia (B-ALL) patients stored in the Tokyo Children’s Cancer Study Group (TCCSG) biobank. Among the 328 … (full text at CIViC)

PMID 30171027 · Ohki et al., 2019 · Open in CIViC

civic